OTCM
EDXC
Market cap57kUSD
Oct 01, Last price
0.00USD
Name
Endexx Corp
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Endexx Corporation operates within the health and wellness industry, specializing in the development and commercialization of products based on cannabidiol (CBD). The company offers a comprehensive range of CBD-infused items, including creams, oils, capsules, extracts, topicals, beverages, chocolates, and specialized formulations for pets. Additionally, it provides health and beauty care solutions derived from hemp. These products are specifically designed to offer therapeutic alleviation of pain and inflammation for both human and animal consumers. Endexx distributes its offerings through its dedicated e-commerce platform, cbdunlimited.com, as well as via other online retailers and brick-and-mortar stores. The entity was previously identified as CBD Unlimited, Inc., until it formally adopted the name Endexx Corporation in May 2020. Its corporate headquarters are located in Cave Creek, Arizona.
Key people
Brad Listermann
Interim Chief Executive Officer · since 2024
Steven Plumb
Chief Financial Officer · since 2022
Todd Davis
Chairman of the Board, President, Treasurer · since 2024
Stephen Herron
Director of Sales · since 2020
Ronald Cotting
Director of Operations · since 2020
Nick Mehdi
Independent Director · since 2022
Irving Minnaker
Independent Director · since 2021
Dustin Sullivan
Independent Director · since 2020
Claude Zdanow
Independent Director · since 2023
Legal address
C/O AFFORDABLE BUSINESS SERVICES INC
1810 E. SAHARA #100
CLARK COUNTY
LAS VEGAS, NV 89104
US
1810 E. SAHARA #100
CLARK COUNTY
LAS VEGAS, NV 89104
US
Headquarters
1350 E. Flamingo Road
Suite 300
Las Vegas, NV 89119
US
Suite 300
Las Vegas, NV 89119
US
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|
| 2024‑09 | 2023‑09 | 2022‑09 | 2021‑09 | 2020‑09 | 2019‑09 | 2018‑09 | 2017‑09 | |
| Income | ||||||||
Revenues | ||||||||
Cost of revenue | ||||||||
Unusual Expense (Income) | ||||||||
NOPBT | ||||||||
NOPBT Margin | ||||||||
Operating Taxes | ||||||||
Tax Rate | ||||||||
NOPAT | ||||||||
Net income | ||||||||
Dividends | ||||||||
Dividend yield | ||||||||
Proceeds from repurchase of equity | ||||||||
BB yield | ||||||||
| Debt | ||||||||
Debt current | ||||||||
Long-term debt | ||||||||
Deferred revenue | ||||||||
Other long-term liabilities | ||||||||
Net debt | ||||||||
| Cash flow | ||||||||
Cash from operating activities | ||||||||
CAPEX | ||||||||
Cash from investing activities | ||||||||
Cash from financing activities | ||||||||
FCF | ||||||||
| Balance | ||||||||
Cash | ||||||||
Long term investments | ||||||||
Excess cash | ||||||||
Stockholders' equity | ||||||||
Invested Capital | ||||||||
ROIC | ||||||||
ROCE | ||||||||
| EV | ||||||||
Common stock shares outstanding | ||||||||
Price | ||||||||
Market cap | ||||||||
EV | ||||||||
EBITDA | ||||||||
EV/EBITDA | ||||||||
Interest | ||||||||
Interest/NOPBT | ||||||||